XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
Stock Appreciation Rights (SARs)
Accumulated Earnings (Deficit)
Accumulated Other Comprehensive Income (Loss)
Total Shareholders' Equity
Non-Controlling Interests
Beginning balance ( in shares) at Dec. 31, 2022   157,682,531          
Beginning balance at Dec. 31, 2022 $ 244,409 $ 698,493   $ (456,120) $ (1,946) $ 240,427 $ 3,982
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) and comprehensive income (loss) 114,264     114,265   114,265 (1)
Share-based compensation 1,186 $ 1,186       1,186  
shares issued for exrcise of stock options (in shares)   34,219          
Shares issued for exercise of stock options (72) $ (72)       (72)  
Shares issued for exercise of stock appreciation rights (in shares)   312,662          
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units 918 $ 918       918  
Ending balance (in shares) at Mar. 31, 2023   158,029,412          
Ending balance at Mar. 31, 2023 359,013 $ 698,833   (341,855) (1,946) 355,032 3,981
Beginning balance ( in shares) at Dec. 31, 2022   157,682,531          
Beginning balance at Dec. 31, 2022 244,409 $ 698,493   (456,120) (1,946) 240,427 3,982
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) and comprehensive income (loss) 109,379            
Ending balance (in shares) at Jun. 30, 2023   158,238,796          
Ending balance at Jun. 30, 2023 355,146 $ 699,851   (346,716) (1,946) 351,189 3,957
Beginning balance ( in shares) at Mar. 31, 2023   158,029,412          
Beginning balance at Mar. 31, 2023 359,013 $ 698,833   (341,855) (1,946) 355,032 3,981
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) and comprehensive income (loss) (4,885)     (4,861)   (4,861) (24)
Share-based compensation 1,554 $ 1,554       1,554  
shares issued for exrcise of stock options (in shares)   45,126          
Shares issued for exercise of stock options (312) $ (312)       (312)  
Shares issued for exercise of stock appreciation rights (in shares)   164,258          
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units 848 $ 848       848  
Ending balance (in shares) at Jun. 30, 2023   158,238,796          
Ending balance at Jun. 30, 2023 355,146 $ 699,851   (346,716) (1,946) 351,189 3,957
Beginning balance ( in shares) at Dec. 31, 2023   162,659,155          
Beginning balance at Dec. 31, 2023 379,205 $ 733,450   (356,258) (1,946) 375,246 3,959
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) and comprehensive income (loss) 3,638     3,639   3,639 (1)
Shares Issued For Cash By At The Market Offering Shares   619,910          
Shares issued for cash by at-the-market offering 4,898 $ 4,898       4,898  
Cash paid to settle and fund employee income tax withholding due upon exercise of stock appreciation rights (552) (552)       (552)  
Share issuance cost 110 110       110  
Share-based compensation 1,345 $ 1,345       1,345  
shares issued for exrcise of stock options (in shares)   29,116 89,794        
Shares issued for exercise of stock options (103) $ (103)       (103)  
Shares issued for the vesting of restricted stock units (in shares)   253,922          
Cash paid to fund employee income tax withholding due upon vesting of restricted stock units 837 $ 837       837  
Ending balance (in shares) at Mar. 31, 2024   163,651,897          
Ending balance at Mar. 31, 2024 387,690 $ 738,297   (352,619) (1,946) 383,732 3,958
Beginning balance ( in shares) at Dec. 31, 2023   162,659,155          
Beginning balance at Dec. 31, 2023 379,205 $ 733,450   (356,258) (1,946) 375,246 3,959
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) and comprehensive income (loss) (2,781)            
Ending balance (in shares) at Jun. 30, 2024   163,661,111          
Ending balance at Jun. 30, 2024 382,736 $ 739,762   (359,037) (1,946) 378,779 3,957
Beginning balance ( in shares) at Mar. 31, 2024   163,651,897          
Beginning balance at Mar. 31, 2024 387,690 $ 738,297   (352,619) (1,946) 383,732 3,958
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) and comprehensive income (loss) (6,419)     (6,418)   (6,418) (1)
Share-based compensation 1,412 $ 1,412       1,412  
shares issued for exrcise of stock options (in shares)   9,214          
Shares issued for exercise of stock options (53) $ (53)       (53)  
Ending balance (in shares) at Jun. 30, 2024   163,661,111          
Ending balance at Jun. 30, 2024 $ 382,736 $ 739,762   $ (359,037) $ (1,946) $ 378,779 $ 3,957